Financing deals

CP Reports
CP Insight
Current Agreements
CP Knowledge Centre
CP Consulting

Derived from Current Agreements, our editors have selected notable financing deals from the life sciences in recent weeks – our Featured deals. Subscribe to our weekly newsletter to be updated on new featured deals and much more.

For comprehensive access to all life science deals as they are announced:

Deal Monitor - part of Current Partnering Insight, Deal Monitor allows you to track recent deals by industry sector, therapy area, technology type and stage of development - access now

Current Agreements - search over 40,000 deals to find benchmarks, monitor target company deal structures, identify companies active in your area(s) of interest, and much more - access now

Featured financing deals

All financing deals: Deal Monitor | Current Agreements

Adaptimmune closes its initial public offering of $175.7 million

May 11, 2015 : Adaptimmune, ipo

Adaptimmune announced the closing of its initial public offering of 11,250,000 American Depositary Shares at a price to the public of $17.00 per ADS. more »

Series B financing for $90 million for Kymab

May 6, 2015 : financing, kymab, series B

Kymab has successfully raised an additional US$50 million to complete a US$90 million Series B financing. more »

Adaptive Biotechnologies Series F financing

May 5, 2015 : adaptive biotechnologies, series F financing

Adaptive Biotechnologies announced the completion of Adaptive’s Series F financing round with a $195 million investment to support several strategic growth initiatives. more »

Series A financing for $41 million for Symbiomix

May 5, 2015 : series a, symbiomix

Symbiomix Therapeutics announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV). more »

Mirna Therapeutics secures $41.8mn series D

May 5, 2015 : financing

Mirna Therapeutics announced the completion of a $41.8 million Series D financing more »

MyoKardia secures series B for $46 million

May 5, 2015 : financing

MyoKardia announced the successful completion of a $46 million Series B financing more »

Intarcia announces $225 million synthetic royalty deal

May 5, 2015 : financing

Intarcia Therapeutics announced the closing of a $225 million synthetic royalty financing more »

CRISPR Therapeutics gains $64mn in series A and B

April 30, 2015 : financing

CRISPR Therapeutics announced the closing of a Series A and Series B financing totaling USD 64 million more »

GW Pharma brings in $179mn in public offering

April 30, 2015 : financing

GW will issue 1,600,000 American Depositary Shares (“ADSs”), representing 19,200,000 ordinary shares of GW, at a price to the public of $112.00 per ADS on the NASDAQ Global Market more »

Jounce Therapeutics gains series B financing for $56 million

April 28, 2015 : financing

Jounce Therapeutics announced the successful completion of a $56 million oversubscribed Series B financing more »

« Page 1, 2, 3 ... 106, »

Derived from Current Agreements, more featured partnering deals by category:

Big pharma

Pfizer creates breaking news with Allergan purchase

November 23, 2015

When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership

August 10, 2015

Boehringer Ingelheim acquires Pharmaxis’ anti-inflammatory candidate

May 18, 2015

View more featured deals | all deals at Deal Monitor

Big biotech

When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership

August 10, 2015

Morphosys acquires Lanthio Pharma

May 7, 2015

Alexion to buy Synageva Biopharma

May 5, 2015

View more featured deals | all deals at Deal Monitor

Pharma

Pfizer creates breaking news with Allergan purchase

November 23, 2015

When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership

August 10, 2015

Pfizer in asset purchase and option to acquire AM-Pharma

May 12, 2015

View more featured deals | all deals at Deal Monitor

Biotech

When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership

August 10, 2015

Veracyte banks $40 million private placement

April 28, 2015

MedImmune and Immunocore partner for melanoma combinations

April 20, 2015

View more featured deals | all deals at Deal Monitor

Diagnostics

Ventana and Astellas in automated tissue diagnostics pact

April 15, 2015

Roche acquires Signature Diagnostics for access to translational oncology and genomics

February 12, 2015

Personalis gains $33 million series C

January 14, 2015

View more featured deals | all deals at Deal Monitor

Medical device

Abbott to distribute Sekiui’s coagulation testing solutions

April 15, 2015

Mallinckrodt acquires Ikaria for $2.3bn

March 5, 2015

Intuitive Surgical wins $430m surgical robotic systems contract

March 5, 2015

View more featured deals | all deals at Deal Monitor

Drug delivery

Janssen and Ichor Medical enter hep B vaccine delivery alliance

April 14, 2015

Sanofi Pasteur and VBI Vaccines in formulation pact

April 9, 2015

Sanofi and Vect-Horus collaborate to transport therapeutic antibodies into brain

January 20, 2015

View more featured deals | all deals at Deal Monitor

Print Friendly, PDF & Email